Genetic test aims to stop drug side effects before they start
NCT ID NCT06322238
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a genetic test can help doctors choose safer drugs and doses for 39 common medications. 66 adults getting a new prescription will receive the test, and researchers will track side effects like muscle aches, fainting, or mood changes for 48 weeks. The goal is to see if this approach reduces harmful drug reactions in everyday primary care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Pharmacogenetic (PGx) panel test
- What this could lead to
- If successful, this could show that a simple genetic test before prescribing common drugs reduces side effects and improves treatment in everyday primary care.
- What could go wrong
- This is a small, early-phase study at one health system, so results may not apply broadly. The test may not prevent all side effects, and some risks are still possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG METABOLISM, POOR, CYP2C19-RELATED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55902, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your DNA predict how you respond to a diabetes drug?
- Your DNA could determine if your birth control works
- Personalized dosing for kids with dystonia? new study investigates genetic factors
- ER genetic test aims to cut repeat trips to hospital
- Can a shorter bladder cancer treatment time cut side effects?
- Can your genes guide better depression treatment? new trial aims to find out.